G1 Therapeutics to Provide Fourth Quarter and Full Year 2020 Financial Results and Business Update on February 24, 2021

Rhea-AI Summary

G1 Therapeutics, Inc. (GTHX) will host a webcast and conference call on February 24, 2021, at 4:30 p.m. ET to provide a corporate and financial update for Q4 2020 and the full year. Interested parties can join by dialing (866) 763-6020 for domestic calls or (210) 874-7713 for international calls, using conference code 5267698. The event will be accessible via the company’s Events & Presentations page. G1 Therapeutics focuses on developing therapies for cancer, including its product COSELA™ (trilaciclib) and has a pipeline for various solid tumors.

Positive

• Upcoming corporate and financial update may provide insights into G1 Therapeutics' performance.
• Company focuses on improving cancer therapies, indicating strong market potential.

Negative

• No specific financial metrics or results were disclosed prior to the upcoming call.

RESEARCH TRIANGLE PARK, N.C., Feb. 17, 2021 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, will host a webcast and conference call to provide a corporate and financial update for the fourth quarter and full year of 2020 on Wednesday, February 24, 2021 at 4:30 p.m. ET.

The live call may be accessed by dialing (866) 763-6020 (domestic) or (210) 874-7713 (international) and entering the conference code: 5267698. The live and archived webcast will be available on the Events & Presentations page of http://www.g1therapeutics.com.

About G1 Therapeutics
G1 Therapeutics, Inc. is a commercial-stage biopharmaceutical company focused on the discovery, development and delivery of next generation therapies that improve the lives of those affected by cancer, including the Company’s first commercial product COSELA™ (trilaciclib). G1 has a deep clinical pipeline evaluating targeted cancer therapies in a variety of solid tumors, including colorectal, breast, lung, and bladder cancers. G1 Therapeutics is based in Research Triangle Park, N.C. For additional information, please visit www.g1therapeutics.com and follow us on Twitter @G1Therapeutics.

Contact:
Will Roberts
G1 Therapeutics, Inc.
Vice President, Investor Relations & Corporate Communications
(919) 907-1944
wroberts@g1therapeutics.com

FAQ

When will G1 Therapeutics provide its financial results?

G1 Therapeutics will provide its financial results on February 24, 2021.

What is the ticker symbol for G1 Therapeutics?

The ticker symbol for G1 Therapeutics is GTHX.

What is G1 Therapeutics known for?

G1 Therapeutics is known for developing therapies for cancer, including COSELA™.

How can I listen to the G1 Therapeutics conference call?

You can listen to the call by dialing (866) 763-6020 for domestic calls or (210) 874-7713 for international calls.